MAXIMIZING POSITIVE SYNERGIES - World Health Organization

the capacity for timely reporting. However, there appears to be a gradual transfer of management
capabilities from the national level to sub-national levels.
The influx of resources from the Global Fund is perceived to have accelerated the decentralization
of the governance of disease care, with non-governmental organizations (NGOs) playing a greater
role—particularly at peripheral levels in which there were no government-run facilities.
Nevertheless, the extent of decentralization was limited by human resources capacity. The role of
multilateral institutions, such WHO and the United Nations Children’s Fund (UNICEF), in the
overseeing management and the disbursement of funds was appreciated.
GHIs have also encouraged government partnerships with NGOs, both local and international, the
private sector and academia. Private clinics and organizations have taken more active roles in
HIV/TB/malaria care, slightly alleviating the burden on the government-run health facilities. The
private sector has also partnered with government in the distribution of bed nets, while the
national university’s Faculty of Medicine has been involved in training students on research topics
related to the target diseases.
Table 2 Global Health Initiative Investments*
*Full data sources for all indicators are provided in Annex 1
Global Fund
Round & Disease Priority Approved (in US$) Disbursed (in US$)
Round 2, HIV/AIDS 24,904,652 23,056,692
Round 4, HIV/AIDS 15,126,131 8,495,262
Round 4, Malaria 16,663,897 12,671,585
Round 4, TB 4,569,039 3,111,176
Round 7, HIV/AIDS 15,799,899 1,845,868
Round 8, Malaria 13,324,208 0
TOTAL: 90,287,826 49,180,583
GAVI
Disease Priority Amount Approved (in US$)
Pentavalent vaccine 5,345,000
Yellow fever vaccine 1,604,000
Vaccine introduction grant 200,000
Injection safety 140,900
Immunization services support 1,611,360
Health systems strengthening 3,163,000
TOTAL: 12,064,226
43